Protein marker test for breast cancer
Part of Cancer, Skin clinical trials.
This study looks at a specific protein in breast cancer tissue to see if it can help doctors understand the cancer better. It involves testing tissue samples from women with breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman diagnosed with breast cancer.
- Your diagnosis is confirmed by biopsy or imaging.
- You have not yet started chemotherapy or radiation therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for circulating tumor cells—cancer cells that may travel in the blood—after standard breast cancer treatment, including chemotherapy before surgery and surgery itself. It may help doctors understand who might be at higher risk and tailor follow-up care.
This study looks at a blood marker called IL-7 to see if it can help with breast cancer. It aims to find out if this marker might be useful for diagnosis or follow-up.
This study tests a new blood test that measures enzyme activity to detect localized cancer. It is for people with newly diagnosed, untreated breast, lung, or pancreatic cancer, as well as healthy volunteers.
This study measures a blood marker called progastrin (at diagnosis and during treatment) to see how well it predicts response or outcomes. It may help doctors choose or monitor treatment more precisely for several cancer types.
This study looks at a specific gene (PCGEM1) in breast cancer tissue to see if it can help predict how the disease may progress. It may lead to better tailored treatments for people with breast cancer.
This study looks at proteins and imaging patterns (from tissue, fluid near the tumor, and blood) to better understand breast cancer markers. It may help researchers find clues that doctors can use to evaluate breast nodules and newly diagnosed invasive breast cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.